Apeel Sciences develops science-backed, technology-supported solutions that help improve the produce experience on the shelf by creating an extra 'peel' of protection for fruits and vegetables. This extra peel keeps moisture in and oxygen out, slowing down respiration, oxidation, and water loss for longer freshness.

James Rogers

Apeel Underwear

Apeel Sciences

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Austin Che

Tom Knight

Jason Kelly

Barry Canton

Reshma Shetty

Ginkgo Bioworks Holdings, Inc.

Innoterra enables the agri-food ecosystem through digital connectivity, connecting Indian retailers and buyers with global farmers and sellers transparently and fairly. It offers tech-based solutions for various agricultural sectors, including dairy, food products, and bioscience.

Innoterra

Apeel's evolving technology stack is built on an unprecedented understanding of produce quality and shelf life. This has only deepened as the use of data and technology have given partners a powerful way to accurately and efficiently evaluate produce for ripeness, freshness, and other attributes. Apeel is developing science-backed, technology-supported solutions that help improve the produce experience on shelf.

Armentum Partners

ATEL Growth Capital

SLR Investment

SLR Capital Partners

Rock Creek Capital

Tao Capital Partners

Upfront Ventures

Viking Global Investors

Katy Perry

Oprah Winfrey

Santa Barbara Angel Alliance

K3 Ventures

Mirae Asset Capital

Sweetwater Capital Partners

Temasek Holdings

Tenere Capital

Andreessen Horowitz

Anne Wojcicki

Michael Ovitz

Susan Wojcicki

International Finance Corporation

Astanor Ventures

KAAN Ventures

Redbadge Pacific

Apeel

Metric
Company Name	Apeel Sciences	Ginkgo Bioworks Holdings, Inc.	Innoterra
Symbol		DNA
MSH ID	COM:APEEL	COM:GINKGOBIOWORKS	COM:INNOTERRA
Market	PRIVATE	STOCKS	PRIVATE
Sector	Consumer Goods	Healthcare	Consumer Services
Industry	Biotechnology Research	Biotechnology	Agri-tech
Country	US	US	IN
Stage	Venture Round	Grant	Grant
Employee Count	298	1.22K
Website	apeel.com	ginkgobioworks.com	innoterra.com
LinkedIn	apeel	ginkgo-bioworks	innoterra
Founders

Metric
Market Cap		725.64M
Enterprise Value
Monthly Web Traffic	23.10K	20.69K	1.35K
Web Traffic Growth	-0.01	-0.17	0.72
Valuation
Raised Capital			6.30M

Metric
Revenue		251.46M
Revenue (LTM)
Revenue (NTM)
Gross Profit		142.64M
EBITDA		-600.68M
Operating Income		-672.23M
Net Income		-892.87M
EPS		-0.46
Diluted EPS		-0.46
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.75
Operating Profit Margin		-3.34
EBITDA Margin		-2.39
Net Profit Margin		-3.55
Return on Equity		-0.65
Return on Assets		-0.54
Return on Capital Employed		-0.51

COM:APEEL

Apeel Sciences

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		-2.78
P/B Ratio		1.90
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		93.70
EV Multiple		-1.34

Metric
Days Sales Outstanding		73.17
Days Payables Outstanding		50.57
Days Inventory Outstanding		0.27
Operating Cycle		46.33
Cash Conversion Cycle		-7.39
Asset Turnover		0.15

Metric
Operating Cash Flow		-295.50M
Free Cash Flow		-336.30M
Cash Flow to Debt		-0.63
Operating Cash Flow/Sales		-1.14
Free Cash Flow Yield		-0.16

Metric
Cash & Equivalents		948.86M
Accounts Receivable		50.07M
Inventory		46K
Goodwill		49.24M
Debt to Capitalization		0.35
Debt to Assets		0.20
Current Ratio		6.78
Quick Ratio		5.98

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue		0.94
R&D to Revenue		2.05
SG&A to Revenue		1.32